Geertrui Vanhove serves as Executive at Insys Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Geertrui Vanhove has executed 5 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 15, 2022 involved receiving (via award) 9,578 shares valued at $3.9K.
Geertrui Vanhove currently holds 32,412 shares of Insys Therapeutics, Inc. (INSY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Geertrui Vanhove has been a net neutral trader of INSY stock. They have purchased $0 and sold $0 worth of shares.
Geertrui Vanhove's most recent insider trade was on Dec 15, 2022, when they sold 9,578 shares at $0.41 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Mar 4, 2019 | INSY | $0 | Award | 8,083 | $N/A | Discretionary |
| Apr 2, 2018 | INSY | $0 | Award | 6,000 | $N/A | Discretionary |
| Apr 2, 2018 | INSY | $0 | Award | 6,000 | $N/A | Discretionary |